Nuvation Bio Inc.

NYSE:NUVB

Biotechnology

Healthcare
$3.81 +1.03%

+$0.06 today

Market cap
$1.34B
Beta
1.56
P/E (TTM)
-12.8
EPS (TTM)
-$0.42
52W Low $1.81High $9.75

Volume 9.92M

Average 4.07M

Income Statement

Follow revenue through to earnings.

Revenue

$62.90M

FY 2025 · Annual

+699.0% YoY

Operating Income

-$213.06M

FY 2025 · Annual

Net Income

-$204.63M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0007.87M62.9M
Cost of Revenue0007.08M8.44M
Gross Profit000795K54.46M
Gross Margin———10.1%86.6%
Research & Development69.04M87.82M71.29M524.19M115.11M
Selling, General & Admin24.28M31.92M28.53M69.23M151.56M
Operating Expenses93.32M119.73M99.82M593.42M267.52M
Depreciation & Amortization184K199K222K683K1.74M
EBITDA(86.66M)(104M)(75.58M)(566.92M)(189.21M)
EBITDA Margin———-7200.7%-300.8%
Operating Income(93.32M)(119.73M)(99.82M)(592.63M)(213.06M)
Operating Margin———-7527.3%-338.7%
Interest Income2.96M7.45M24.61M27.06M21.43M
Interest Expense000341K13.68M
Other Income / Expenses6.47M15.54M24.02M24.69M8.44M
Income Before Tax(86.85M)(104.2M)(75.8M)(567.94M)(204.63M)
Pre-Tax Margin———-7213.8%-325.3%
Income Tax Expense00000
Net Income(86.85M)(104.2M)(75.8M)(567.94M)(204.63M)
Net Margin———-7213.8%-325.3%
EPS (Basic)(0.44)(0.48)(0.35)(2.11)(0.60)
EPS (Diluted)(0.44)(0.48)(0.35)(2.11)(0.60)
Weighted Avg Shares197.89M216.72M218.88M268.77M341.54M
Weighted Avg Shares (Diluted)197.89M216.72M218.88M268.77M341.54M

NUVB Earnings Waterfall · TTM

NYSE:NUVB · Revenue to Net Income

Key Ratios

EPS$-0.44
Gross Margin91.0%
Net Margin-176.1%
P/E Ratio8.8
P/S Ratio62.7

Analysis

$169.9M of revenue converted into -$149.8M of net income for the selected period. Gross margin is 91.0% and net margin is -176.1%, showing how much revenue survives after costs and taxes. EPS is $-0.44, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipAug 21, 2026
8-KCurrent reportAug 6, 2026
10-QQuarterly reportAug 6, 2026

How much revenue does NUVB generate?

Nuvation Bio Inc. (NUVB) reported $62.90M of revenue in fiscal 2025.

Is NUVB profitable?

Nuvation Bio Inc. (NUVB) reported -$204.63M of net income, with a net margin of -325.3%.